Prevention of macrovascular complications in patients with type 2 diabetes mellitus: Review of cardiovascular safety and efficacy of newer diabetes medications

Lack of conclusive beneficial effects of strict glycemic control on macrovascular complications has been very frustrating for clinicians involved in care of patients with diabetes mellitus (DM). Highly publicized controversy surrounding cardiovascular (CV) safety of rosiglitazone resulted in major c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kant, Ravi, Munir, Kashif M, Kaur, Arshpreet, Verma, Vipin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571484/
https://www.ncbi.nlm.nih.gov/pubmed/31231455
http://dx.doi.org/10.4239/wjd.v10.i6.324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571484/
https://www.ncbi.nlm.nih.gov/pubmed/31231455
http://dx.doi.org/10.4239/wjd.v10.i6.324

Ejemplares similares